Vivos (RDGL) Share-based Compensation (QoQ) (2010 - 2025)
Vivos (RDGL) Share-based Compensation (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Vivos | 24.08 Mn | 22.53 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 112.27% |
| Sep 30, 2025 | 128.03% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | -76.00% |
| Dec 31, 2024 | -65.23% |
| Sep 30, 2024 | 1,397.68% |
| Jun 30, 2024 | -60.45% |
| Dec 31, 2022 | 157.86% |
| Sep 30, 2022 | -200.00% |
| Jun 30, 2022 | 1,426.67% |
| Mar 31, 2022 | 131.51% |
| Mar 31, 2018 | -88.90% |
| Dec 31, 2017 | -83.34% |
| Sep 30, 2017 | -10.26% |
| Jun 30, 2017 | -4.18% |
| Sep 30, 2016 | -95.31% |
| Mar 31, 2015 | -86.83% |
| Dec 31, 2014 | 3,908.30% |
| Mar 31, 2014 | -76.14% |
| Dec 31, 2013 | 602.86% |